Chinese Company May Help Ease US Shortage of Cancer Drug
When importing drugs, the FDA stressed that regulators carefully assess product quality and manufacturing processes to ensure patient safety
Diagnosis & Disease Information
Real-World mCSPC First-Line Treatment Intensification Remains Low
Study findings highlight the need for earlier mCSPC treatment intensification by urologists and oncologists.
Trimodality Therapy and Radical Cystectomy Produce Similar Outcomes in MIBC
Trimodality therapy produces similar oncologic outcomes as radical cystectomy in patients with muscle-invasive bladder cancer, a new study suggests.
AUA, SUO Issue New Guideline on Nonmetastatic UTUC
The new guideline aims to limit toxicity and improve cancer control and survival in patients with UTUC.
Outcomes of Chemotherapy-Related Febrile Neutropenia Vary by Region
Research has revealed regional disparities in outcomes for patients who are hospitalized with chemotherapy-related febrile neutropenia in the United States.
Bladder Cancer Trimodal Therapy’s Effects on Long-Term Renal Function Described
Renal function declines slightly in the first year of follow-up and then remains stable through 10 years.
Black Men With Metastatic Prostate Cancer More Frequently Refuse Chemotherapy
A recent study found a racial disparity in the use of guideline-concordant treatment for metastatic prostate cancer.
Chemoradiation, Cystectomy Offer Similar Survival in Octogenarians with MIBC
Study findings suggest that chemoradiation therapy could be considered an alternative to surgery in this patient population.
Black Patients More Likely to Have Heart Damage Following Chemo
Compared with White patients, Black patients have 71% higher odds of cardiotoxicity
Maintenance Avelumab Uptake Modest in Advanced Urothelial Carcinoma
Clinicians may have limited awareness of maintenance immunotherapy for urothelial carcinoma.
- Loading...
Loading...
Next post in Bladder Cancer
Loading... 
Loading...